August 30, 2024
As a resident, rheumatologist Daniel Albert, MD, did his first volunteer mission to Afghanistan. The clinic had one portable chest x-ray machine, and physicians could order […]
August 29, 2024
TOPLINE: Exposure to environmental particulate matter ≤ 10 μm in diameter (PM10) is associated with an increased risk for giant cell arteritis, particularly in older individuals […]
August 28, 2024
TOPLINE: Children with juvenile idiopathic arthritis (JIA) who participated in a Juvenile Arthritis Support Program reported higher satisfaction with care and better overall health after 12 […]
August 27, 2024
TOPLINE: Patients with axial spondyloarthritis (axSpA) treated with bimekizumab had a lower incidence of uveitis than those receiving placebo in pooled clinical trial data. METHODOLOGY: Researchers […]
August 26, 2024
(Reuters) – Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in […]
August 23, 2024
TOPLINE: Treatment with etanercept led to faster disease control initially in patients with early rheumatoid arthritis (RA) who had an insufficient early response to methotrexate and […]
August 22, 2024
Since the first US Food and Drug Administration approval of a Janus kinase (JAK) inhibitor in 2011, the number of these medications available — and their […]
August 22, 2024
TOPLINE: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for all-cause mortality and major adverse cardiovascular events (MACE) than for dipeptidyl […]
August 21, 2024
TOPLINE: A smartphone app that delivers acceptance and commitment therapy (ACT), a type of cognitive behavioral therapy, improves overall well-being and reduces the severity of pain, […]